156 Search Results

q=Grants

Search Again


Deborah Donnell , PhD

Email: deborah@scharp.org

Phone: (206) 667-5661

Dr. Donnell is a Principal Staff Scientist in the Vaccine and Infectious Disease Institute (VIDI). She is the Principal Investigator of the HIV Prevention Trials Network Statistical and Data Management Center. The scientific faculty, drawing from the University of Washington Biostatistics department and the Population Sciences Program in VIDI, are responsible for the design and analysis of Phase III clinical trials to access the efficacy of biomedical and behavioral interventions to prevent the transmission of HIV

View Bio

Adam Drewnowski , PhD

Email: adamdrew@u.washington.edu

Phone: (206) 543-8016

Dr. Drewnowski's interests are in the characterization of dietary patterns, nutrition economics, spatial distribution of obesity rates; and in the development of new metrics to identify foods that are nutrient dense, affordable and sustainable. He currently examines social determinants of health, focusing on the mechanisms behind the observed social gradient in diet quality and body weight. He has developed new methods to estimate monetary costs of individual diets, opening the door to new research on diet quality in relation to diet cost; and his studies on healthy food access make use of GIS techniques and new methods on spatial epidemiology to determine who shops for food where, why, how far from home and for how much.

View Bio

Zhijun Duan , PhD

Email: zjduan@uw.edu

Phone: (206) 543-3363

Dr. Duan's research is focused on the relationship between the form and function of human genomes during development and tumorigenesis. One of the striking features of the eukaryotic nucleus is that chromosomes adopt preferred conformations that vary across different tissues and developmental stages.

View Bio

Marianne Dubard-Gault , MD, MS

Email: mdg2019@uw.edu

Dr. Dubard-Gault is the medical director of the Cancer Genetics Program at SCCA. Her main research interest is to better understand how genetic information influences patients’ decision-making about health care and life choices. She is also interested in exploring ways to help people better access medical genetic information, talk about it with their families and use that knowledge to make decisions that fit their goals.

View Bio

Paul Edlefsen , PhD

Email: pedlefse@scharp.org

Phone: (206) 667-4086

Dr. Edlefsen's research interests include statistical and computational methods for bioinformatics applications. He is also interested in statistical modeling techniques for genome science analysis.

View Bio

Evan Eichler , PhD

Email: eee@gs.washington.edu

Phone: (206) 543-9526

Dr. Eichler's long term research goal is to understand the evolution, pathology and mechanism(s) of recent gene duplication and DNA transposition within the human genome. His work involves the systematic discovery of these regions, the development of methods to assess their variation, the detection of signatures of rapid gene evolution and ultimately the correlation of this genetic variation with phenotypic differences within and between species.

View Bio

Robert Eisenman , PhD

Email: eisenman@fredhutch.org

Phone: (206) 667-4445

Dr. Eisenman studies how cell proliferation, growth, and differentiation are regulated through the actions of transcriptional networks, and how this regulation is subverted during tumor progression. Specifically, his laboratory research focuses on gaining a deeper understanding of the mechanisms of an oncogenic transcription factor network (Myc/Max/Mxd) which is fundamental in all cancers.

View Bio

Min Fang , MD, PhD

Email: fangm@uw.edu

Phone: (206) 288-1390

Dr. Fang's research focus is on the genomics and combinatorial genetics/epigenetics of human neoplasia. She is combining classical genetic approaches of mapping, karyotyping, and functional genetics with new genomic tools including microarray, comparative genome hybridization, and next-generation sequencing, to identify genetic and epigenetic aberrations in cancer that may serve as actionable biomarkers for treatment decision making for individual patients.

View Bio

Meghan Flanagan , MD, MPH

Email: mrf22@uw.edu

Phone: (206) 667-6736

Dr. Flanagan's research areas include lymph node evaluation, patient satisfaction and chemoprevention among women at high risk of developing breast cancer. She is also interested in exploring how to improve cancer-related outcomes and access to health services.

View Bio

Youyi Fong , PhD

Email: youyifong@gmail.com

Phone: (206) 667-1093

Dr. Fong's research interests are in statistical problems in biological assays, biological sequence analysis, and stochastic optimization.

View Bio

Jordan Gauthier , MD, MSc

Email: jgauthier@fredhutch.org

Phone: (206) 667-2713

Much of Dr. Gauthier's research has been focused on improving outcomes for patients treated with BMT or CAR T-cell therapy. Through his work, he has identified factors that can help predict the success of CAR T-cell therapy for patients who have leukemia and lymphoma.

View Bio

Gustavo Glusman , PhD

Email: gustavo.glusman@systemsbiology.org

Phone: (206) 732-1273

Dr. Glusman uses computational approaches to investigate genome structure and evolution; multi-gene families; prediction and discovery of genes and transcripts; genes not coding for proteins; visualization of complex data; and image analysis. His algorithms are contributing to the discovery of genes that are not easily identified using standard procedures, to the interpretation of large-scale transcriptomic and genomic data, and to the study of disease genetics.

View Bio

Raphael Gottardo , PhD

Email: raph@rglab.org

Phone: (206) 667-4076

Dr. Gottardo is the principal investigator in the Gottardo Lab and Fred Hutch. His research focuses on developing methods and tools for high throughput, high dimensional experiments with applications in vaccine research and immunology. His team also works on flow cytometry, peptide microarrays, next generation sequencing, Bayesian inference and computation, and statistical computing.

View Bio

Taran Gujral , PhD, Msc

Email: tgujral@fredhutch.org

Phone: (206) 667-4149

Cells respond to external stimuli by activating nonlinear and highly interconnected networks of signaling proteins. Dr. Gujral's work focuses on understanding how these networks are wired in different cell types and how they influence response to growth factors or cytotoxic agents using both hypothesis driven and systems-based data-driven approaches. His lab combines approaches from molecular genetics with cell and systems biology to study a recently discovered Wnt5-Fzd2 signaling pathway in metastasis as well as cell-to-cell contact in regulating cell fate decisions.

View Bio

Brandon Hadland , MD, PhD

Email: bhadland@fredhutch.org

Phone: (206) 667-1095

Dr. Brandon Hadland is a hematologist/oncologist and stem cell transplantation expert who treats young patients in Seattle Children’s Hospital transplant service. His research focuses on the origin of hematopoietic stem cells, which give rise to blood and immune cells. He harnesses new technologies to simultaneously analyze gene activities across the many different cell types within the physical site where the stem cells evolve and to characterize interactions between those various cells. He aims to identify the specific biological signals that trigger the formation of blood stem cells. His ultimate goal is to generate new sources of blood stem cells that could one day be used to correct inherited, blood-based diseases.

View Bio

Michael Haffner , MD, PhD

Email: mhaffner@fredhutch.org

Dr. Haffner’s lab focuses on elucidating alterations of the cytoskeleton in solid tumors with a focus on prostate cancer. For instance, they have recently described a novel protein, named AIM1 that regulates cytoskeletal organization by binding to actin, a major component of the cytoskeleton. When AIM1 is present, the cells' scaffolding keeps it rigid and correct shape. When AIM1 is lost, cells can remodel their cytoskeleton more frequently, change their shape and become capable of invading and migrating to distant locations. Notably, AIM1 function is disrupted in many solid tumors and genomic alterations of AIM1 are associated with aggressive tumor growth. The goal of these studies is to understand the mechanisms that govern changes in cell architecture to explore such cancer specific changes for therapeutic targeting.

View Bio

Evan Hall , MD, MPhil

Email: evanh@seattlecca.org

Phone: (206) 606-2496

Dr. Hall's research focuses on how to measure and improve quality of life for patients with cancer. His other areas of interest include physician-patient communication, the health economics of cancer and the benefits of novel modes of patient and caregiver social support, such as online communities.

View Bio

Jared Harwood , MD, MBA

Email: harwoodj@uw.edu

Phone: (206) 221-4469

Dr. Harwood specializes in the evaluation and treatment of bone and soft tissue tumors of the extremities and pelvis and is well versed in general Orthopaedic care. His clinical interests include limb-sparing tumor resections and reconstructions, percutaneous osseointegrated prostheses, targeted muscle re-innervation, prophylactic treatment of metastatic disease, and revision joint replacement. His research interests include efficiency and sustainability of healthcare, opioid stewardship, process improvement, mentorship/leadership, communication, and outcomes in the treatment of metastatic disease.

View Bio

Stephen Hawes , PhD

Email: hawes@u.washington.edu

Phone: (206) 616-9744

Dr. Hawes's primary interests are in human papillomavirus (HPV) and human immunodeficiency virus (HIV). His current research is conducted in Seattle and Senegal, West Africa and concerns the role of HIV, HPV and other sexually transmitted infections in the natural history of cervical neoplasia and cancer, as well as the study of biomarkers for various cancers including cancer of the cervix, anus, lung, breast, and skin. He is also interested in Alzheimer's disease.

View Bio